TY - JOUR
T1 - Simplified kinetic analysis of tumor 18F-FDG uptake
T2 - A dynamic approach
AU - Sundaram, Senthil K.
AU - Freedman, Nanette M.T.
AU - Carrasquillo, Jorge A.
AU - Carson, Joann M.
AU - Whatley, Millie
AU - Libutti, Steven K.
AU - Sellers, David
AU - Bacharach, Stephen L.
PY - 2004/8/1
Y1 - 2004/8/1
N2 - Standardized uptake value (SUV) is often used to quantify 18F-FDG tumor use. Although useful, SUV suffers from known quantitative inaccuracies. Simplified kinetic analysis (SKA) methods have been proposed to overcome the shortcomings of SUV. Most SKA methods rely on a single time point (SKA-S), not on tumor uptake rate. We describe a hybrid between Patlak analysis and existing SKA-S methods, using multiple time points (SKA-M) but reduced imaging time and without measurement of an input function. We compared SKA-M with a published SKA-S method and with Patlak analysis. Methods: Twenty-seven dynamic 18F-FDG scans were performed on 11 cancer patients. A population-based 18F-FDG input function was generated from an independent patient population. SKA-M was calculated using this population input function and either a short, late, dynamic acquisition over the tumor (starting 25-35 min after injection and ending ∼55 min after injection) or dynamic imaging 10 or 25 min to ∼55 min after injection but using only every second or third time point, to permit a 2- or 3-field-of-view study. SKA-S was also calculated. Both SKA-M and SKA-S were compared with the gold standard, Patlak analysis. Results: Both SKA-M (1 field of view) and SKA-S correlated well with Patlak slope (r > 0.99, P < 0.001, and r = 0.96, P < 0.001, respectively), as did multilevel SKA-M (r > 0.99 and P < 0.001 for both). Mean values of SKA-M (25-min start time) and SKA-S were statistically different from Patlak analysis (P < 0.001 and P < 0.04, respectively). One-level SKA-M differed from the Patlak influx constant by only -1.0% ±- 1.4%, whereas SKA-S differed by 15.1% ±- 3.9%. With 1-level SKA-M, only 2 of 27 studies differed from Ki by more than 20%, whereas with SKA-S, 10 of 27 studies differed by more than 20% from K i. Conclusion: Both SKA-M and SKA-S compared well with Patlak analysis. SKA-M (1 or multiple levels) had lower variability and bias than did SKA-S, compared with Patlak analysis. SKA-M may be preferred over SUV or SKA-S when a large unmetabolized 18F-FDG fraction is expected and 1-3 fields of view are sufficient.
AB - Standardized uptake value (SUV) is often used to quantify 18F-FDG tumor use. Although useful, SUV suffers from known quantitative inaccuracies. Simplified kinetic analysis (SKA) methods have been proposed to overcome the shortcomings of SUV. Most SKA methods rely on a single time point (SKA-S), not on tumor uptake rate. We describe a hybrid between Patlak analysis and existing SKA-S methods, using multiple time points (SKA-M) but reduced imaging time and without measurement of an input function. We compared SKA-M with a published SKA-S method and with Patlak analysis. Methods: Twenty-seven dynamic 18F-FDG scans were performed on 11 cancer patients. A population-based 18F-FDG input function was generated from an independent patient population. SKA-M was calculated using this population input function and either a short, late, dynamic acquisition over the tumor (starting 25-35 min after injection and ending ∼55 min after injection) or dynamic imaging 10 or 25 min to ∼55 min after injection but using only every second or third time point, to permit a 2- or 3-field-of-view study. SKA-S was also calculated. Both SKA-M and SKA-S were compared with the gold standard, Patlak analysis. Results: Both SKA-M (1 field of view) and SKA-S correlated well with Patlak slope (r > 0.99, P < 0.001, and r = 0.96, P < 0.001, respectively), as did multilevel SKA-M (r > 0.99 and P < 0.001 for both). Mean values of SKA-M (25-min start time) and SKA-S were statistically different from Patlak analysis (P < 0.001 and P < 0.04, respectively). One-level SKA-M differed from the Patlak influx constant by only -1.0% ±- 1.4%, whereas SKA-S differed by 15.1% ±- 3.9%. With 1-level SKA-M, only 2 of 27 studies differed from Ki by more than 20%, whereas with SKA-S, 10 of 27 studies differed by more than 20% from K i. Conclusion: Both SKA-M and SKA-S compared well with Patlak analysis. SKA-M (1 or multiple levels) had lower variability and bias than did SKA-S, compared with Patlak analysis. SKA-M may be preferred over SUV or SKA-S when a large unmetabolized 18F-FDG fraction is expected and 1-3 fields of view are sufficient.
KW - F-FDG
KW - Patlak
KW - Standardized uptake value
UR - http://www.scopus.com/inward/record.url?scp=4544381250&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4544381250&partnerID=8YFLogxK
M3 - Article
C2 - 15299057
AN - SCOPUS:4544381250
SN - 0161-5505
VL - 45
SP - 1328
EP - 1333
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 8
ER -